BPOM Issues Emergency Use Authorization for Moderna Vaccine
Translator
Editor
July 2, 2021 | 01:02 pm
TEMPO.CO,Jakarta - The Food and Drug Monitoring Agency (BPOM) has issued an emergency use authorization (EUA) for the Covid-19 vaccine produced by the United States,Moderna.
“We added one more vaccine brand that has received EUA from the BPOM, namely the Moderna vaccine,” said the BPOM Head Penny Lukito in a press conference on Friday, July 2, 2021.
Penny said Moderna was the first vaccine with an mRNA platform that was granted an emergency use authorization by BPOM. This vaccine brand would enter Indonesia through the COVAX scheme.
Based on the results of phase III clinical trials, Penny said the vaccine efficacy showed 94.1 percent in the 18-65 year age group and 86.4 percent in people aged 65 and over.
This vaccine was also said to provide a similar safety and efficacy profile in comorbid groups. Penny said the U.S.-made vaccine could be given to individuals with chronic lung disease, heart disease, severe obesity, diabetes, liver disease, and HIV.
“The POM Agency appreciates the expert team of the national committee for the Covid-19 vaccine assessment and ITAGI who have jointly conducted an intensive study so that the Moderna vaccine EUA can be issued in response to the high vaccine need,” Penny added.
Besides Moderna,BPOM has previously provided EUA for four other vaccine brands, namely CoronaVac produced by Sinovac China, Sinovac vaccine developed by Bio Farma, AstraZeneca, and Sinopharm.
Read: Indonesia to Receive Moderna Vaccine Donation from U.S.
FRISKI RIANA
Recommended
Moderna Recalls Another Lot of COVID-19 Vaccine; BPOM Responds
28 April 2022
The Food and Drug Monitoring Agency (BPOM) says the public should not worry about another recall of Moderna's COVID-19 vaccine Spikevax in Europe.
Canada Approves Moderna COVID-19 Vaccine for Children
18 Maret 2022
Canada approves the use of the Moderna Spikevax (50 mcg) COVID-19 vaccine in children 6 to 11 years old.
Australia Gains First Access to mRNA Vaccine Production
10 Maret 2022
UQ scientists say access to Moderna's mRNA platform will allow for the development of vaccines for neglected and emerging viruses.
People with Full Sinovac Doses Could Get Pfizer Boosters, Minister Says
11 Januari 2022
Indonesia will kick off the booster rollout tomorrow, 12 January.
Indonesia Receives 819,600 Moderna Covid-19 Vaccines from the Netherlands
30 Oktober 2021
Indonesia receives 819,600 doses of Moderna Covid-19 vaccine from the Dutch Government.
Moderna, Pfizer Vaccines Available at Jakarta Healthcare Facilities
16 September 2021
Jakarta Health Agency announced the availability of Moderna and Pfizer Covid-19 vaccines across the city's healthcare facilities.
List of Jakarta Health Facilities Serving Moderna, Pfizer Vaccinations
7 September 2021
The following are healthcare facilities spread across Jakarta that offer Covid-19 vaccinations with Moderna and Pfizer vaccines.
Two Die in Japan after Receiving Moderna Vaccines
28 Agustus 2021
The vaccines were among lots later suspended following the discovery of contaminants, Japan's health ministry said on Saturday.
Differences Between Pfizer and Moderna Vaccines, According to BPOM
27 Agustus 2021
Despite equally coming from the U.S., there are several differences between the Pfizer and the Moderna COVID-19 vaccines, says BPOM.
Officials Get Vaccine Boosters; Health Ministry to Reprimand Regional Offices
26 Agustus 2021
The Health Ministry said the third dose of Covid-19 vaccines or vaccine boosters should only be administered to health workers.
Popular
More Popular
